MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy
Advances in Clinical Chemistry · 2025
DOI: 10.1016/bs.acc.2025.06.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2025. Verfasst von Md Abdur Rahman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh. Hauptthemen laut MEDLINE: Metabolic Syndrome, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 226 Literaturangaben.
Abstract (Originalsprache)
Metabolic syndrome is a group of cardio-metabolic dysfunctions characterized by increased fasting blood glucose, blood pressure, waist circumference, triglycerides, and decreased high-density lipoprotein cholesterol. Globally, the prevalence of metabolic syndrome ranged from 12.5-31.4 %, among which 5-7 % were young adults. Environmental factors, nutrition, and genetic and epigenetic predispositions are thought to interact intricately to cause metabolic disease. MicroRNAs are short, small non-coding RNAs that attach to the target coding sequences and untranslated genomic regions in many cell types, thereby post-transcriptionally suppressing gene expression. The human genome contains around 2000 microRNAs many of which appear linked to a numerous biologic and pathophysiologic processes, such as inflammatory response, angiogenesis, and glucose homeostasis. Many human disorders, including obesity, type 2 diabetes mellitus, and cardiovascular disorders, have been linked to deregulated microRNA expression. More recently, the identification of extracellular microRNAs has highlighted their potential as markers of disease and endocrine signaling molecules. This review provides an overview of microRNA biogenesis and its function in insulin signaling, adipogenesis, biology of pancreatic β-cell, and metabolism. We review current research on microRNAs linked to vascular diabetic complications and metabolic diseases, with a focus on their diagnostic and therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh.
Zitieren
APA
Rahman, M. A., Islam, M. M., Islam, M. M., Ripon, M. A. R., & Hossain, M. S. (2025). MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2025.06.003
Vancouver
Rahman MA, Islam MM, Islam MM, Ripon MAR, Hossain MS. MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy. Advances in Clinical Chemistry. 2025. doi:10.1016/bs.acc.2025.06.003
BibTeX
@article{Rahman2025,
author = {Rahman, Md Abdur and Islam, Md Mahmodul and Islam, Md Monirul and Ripon, Md Abdur Rahman and Hossain, Mohammad Salim},
title = {MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy},
journal = {Advances in Clinical Chemistry},
year = {2025},
doi = {10.1016/bs.acc.2025.06.003}
}
EUVIMED